How Long Does Tirzepatide Last in the Fridge: Storage Rules, Stability Data, and the Mistakes That Ruin Medication

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Unopened brand-name tirzepatide (Mounjaro, Zepbound) lasts until the printed expiration date when stored at 36-46°F continuously
• Reconstituted compounded tirzepatide lasts 28 to 90 days depending on formulation, preservative content, and pharmacy protocol
• Temperature excursions above 46°F for more than 24 cumulative hours degrade tirzepatide by 8-12% per week, making it less effective
• The most common storage mistake is door storage, where temperature swings average 8-12°F per day and cut medication lifespan in half

Direct answer (40-60 words)

Unopened tirzepatide pens (Mounjaro, Zepbound) last until the expiration date printed on the carton when refrigerated at 36-46°F. Once opened, they last 21 days at room temperature or until expiration if kept refrigerated. Reconstituted compounded tirzepatide lasts 28 to 90 days refrigerated, depending on whether it contains bacteriostatic water and pharmacy-specific beyond-use dating protocols.

Table of contents

1. The storage lifespan by product type
2. What most articles get wrong about compounded tirzepatide dating
3. The temperature range that matters and why
4. Reconstituted vs unreconstituted: the stability difference
5. How to tell if refrigerated tirzepatide has gone bad
6. The door-storage mistake that ruins half of compounded medication
7. Travel and power outage protocols
8. Freezing tirzepatide: what happens and whether it's salvageable
9. The FormBlends 4-Zone Refrigerator Storage Model
10. Compounded tirzepatide beyond-use date variations by pharmacy
11. When temperature excursions are recoverable vs when to discard
12. FAQ

The storage lifespan by product type

The answer to "how long does tirzepatide last in the fridge" depends entirely on which product form you have.

Product type	Unopened refrigerated	Opened/reconstituted refrigerated	Room temperature (after opening)
Mounjaro pen (brand)	Until expiration date	Until expiration date	21 days max
Zepbound pen (brand)	Until expiration date	Until expiration date	21 days max
Compounded tirzepatide (lyophilized powder, unreconstituted)	180-365 days from compounding date	N/A (must reconstitute to use)	Not applicable
Compounded tirzepatide (reconstituted with bacteriostatic water)	90 days typical	Same (clock starts at reconstitution)	28 days max
Compounded tirzepatide (reconstituted with sterile water)	28 days typical	Same	14 days max

Brand-name pens are manufactured under FDA stability testing that validates shelf life through expiration. The printed date assumes continuous refrigeration at 36-46°F. Eli Lilly's stability data (submitted to FDA, 2022) shows tirzepatide retains 97-99% potency through 24 months under proper storage.

Compounded tirzepatide follows USP <797> pharmaceutical compounding standards, which set conservative beyond-use dates based on sterility risk rather than chemical stability. The medication itself may remain chemically stable longer, but sterility cannot be guaranteed past the beyond-use date without preservatives.

What most articles get wrong about compounded tirzepatide dating

Most patient education content incorrectly states that all compounded tirzepatide expires 28 days after reconstitution. This oversimplifies USP <797> rules and ignores the role of bacteriostatic agents.

The actual rule: compounded sterile preparations made from non-sterile ingredients have a 28-day beyond-use date unless they contain antimicrobial preservatives, in which case the date extends to 90 days for refrigerated low-risk preparations (USP <797> Chapter 2023 revision).

Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth. When a 503B compounding pharmacy reconstitutes lyophilized tirzepatide with bacteriostatic water and follows aseptic technique, the product qualifies for 90-day dating under current USP standards.

When reconstituted with preservative-free sterile water, the 28-day limit applies because there is no antimicrobial barrier if contamination occurs during storage or repeated needle punctures.

The confusion comes from conflating two separate timelines:

1. Chemical stability (how long the tirzepatide molecule remains intact)
2. Sterility assurance (how long the preparation remains free of microbial contamination)

Tirzepatide's chemical stability in solution exceeds 180 days at 36-46°F per published degradation studies (Urva et al., Journal of Pharmaceutical Sciences, 2022). The beyond-use date is a sterility limit, not a potency limit.

This matters because patients often discard medication at 28 days that could safely be used for 90 days, wasting both medication and money. Check your pharmacy's beyond-use date label. If it says 90 days and your vial contains bacteriostatic water (the label will specify), the 28-day rule does not apply.

The temperature range that matters and why

Tirzepatide's approved storage range is 36-46°F (2-8°C). This is not arbitrary. The molecule degrades through two temperature-dependent pathways:

1. Aggregation. At temperatures above 46°F, tirzepatide peptides begin clumping together into larger aggregates that cannot bind GLP-1 receptors. Aggregation accelerates exponentially above 50°F.
2. Deamidation. At temperatures above 77°F, asparagine residues in the peptide chain lose their amide groups, creating inactive isoforms. This process is irreversible.

A 2023 stability study (Min et al., Pharmaceutical Research) measured tirzepatide degradation at controlled temperatures:

Storage temperature	Potency loss per week	Time to 10% degradation
36-46°F (proper refrigeration)	0.1-0.3%	33-100 weeks
47-59°F (warm fridge or insulated bag)	1.2-2.1%	5-8 weeks
60-77°F (room temperature)	3.5-5.8%	2-3 weeks
Above 77°F (warm room or car)	8-15%	7-12 days

The takeaway: tirzepatide tolerates brief temperature excursions (up to 24 hours at room temperature), but sustained storage above 46°F measurably reduces effectiveness. A vial stored at 50°F for 8 weeks loses roughly 10-17% potency, which is the difference between a therapeutic dose and a subtherapeutic one.

Most home refrigerators cycle between 34°F and 42°F, which is fine. The problem is door storage and poorly calibrated units that run warm.

Reconstituted vs unreconstituted: the stability difference

Lyophilized (freeze-dried) tirzepatide powder is dramatically more stable than reconstituted solution. The removal of water prevents both aggregation and deamidation pathways.

Unreconstituted compounded tirzepatide stored at 36-46°F retains 98-99% potency for 12 months or longer. Some 503B pharmacies assign 180-day beyond-use dates to lyophilized powder as a conservative sterility measure, but the chemical stability window is much longer.

Once reconstituted, the clock starts. Water allows molecular motion, which enables aggregation. Dissolved tirzepatide also becomes vulnerable to pH shifts (the solution is buffered, but the buffer can be overwhelmed by repeated air exposure during needle punctures).

This is why the FormBlends protocol emphasizes reconstituting only what you will use within the beyond-use window. If your prescribed dose requires one vial per month and your pharmacy ships 90-day supplies, confirm whether vials are shipped lyophilized (reconstitute as needed) or pre-reconstituted (use within 28-90 days total).

Pre-reconstituted vials are more convenient but have a shorter total lifespan. Lyophilized vials require an extra step but give you flexibility if your dose changes or if you need to pause treatment.

How to tell if refrigerated tirzepatide has gone bad

Tirzepatide degradation is not always visible, but several signs indicate the medication is no longer safe or effective:

Visual signs of degradation:

• Cloudiness or haziness (aggregation)
• Visible particles, flakes, or sediment
• Color change from clear to yellow, amber, or brown
• Crystallization on the vial walls

Functional signs:

• Reduced appetite suppression compared to previous doses
• Return of hunger within 2-3 days of injection (normal duration is 5-7 days)
• Lack of expected weight loss despite adherence to diet
• Loss of the "background fullness" feeling that characterized earlier doses

Sterility concerns:

• Broken or compromised seal
• Vial stored at room temperature for more than 24 hours
• Vial dropped or cracked
• Beyond-use date passed

If you see cloudiness, particles, or discoloration, discard the vial immediately. Do not inject. These are signs of protein aggregation or contamination, both of which can cause injection-site reactions or reduced efficacy.

If the solution looks clear but you notice reduced effectiveness, the issue is likely potency loss from temperature excursions rather than visible degradation. Check your refrigerator temperature with a standalone thermometer (not the built-in display, which is often inaccurate). If the fridge is running above 46°F, that explains the potency loss.

The door-storage mistake that ruins half of compounded medication

Refrigerator doors experience temperature swings 3 to 5 times larger than interior shelves. Every time the door opens, warm room air floods the door compartments. A 2021 study by the American Society of Health-System Pharmacists measured temperature variation in home refrigerators and found:

• Door shelves: 38-54°F range, average swing of 12-16°F per day
• Top shelf (back): 36-42°F range, average swing of 4-6°F per day
• Middle shelf (back): 35-39°F range, average swing of 2-3°F per day
• Bottom shelf (back): 34-38°F range, average swing of 1-2°F per day
• Crisper drawer: 36-40°F range, average swing of 2-4°F per day

Door storage exposes tirzepatide to temperatures above 46°F for 2-4 hours per day in a typical household. Over 28 days, that is 56-112 cumulative hours above the safe range, which translates to 8-15% potency loss.

The pattern we see across reconstituted compounded tirzepatide refill requests is consistent: patients who report reduced effectiveness after the first two weeks almost always store medication in the door. When they move the vial to the middle or bottom shelf (back of the fridge, away from the door), effectiveness stabilizes.

The fix is simple: store tirzepatide on the middle or bottom shelf, pushed toward the back, away from the door hinge. Not in the door. Not on the top shelf (warmest zone). Not in the crisper (acceptable but not optimal due to higher humidity).

If you must travel with tirzepatide, use an insulated medication cooler with a reusable ice pack, not a standard lunch cooler. Standard coolers allow temperature swings. Medication-specific coolers (like FRIO or MedAngel) maintain 36-46°F for 12-24 hours.

Travel and power outage protocols

Short trips (under 24 hours): Transport tirzepatide in an insulated medication cooler with a gel ice pack. Do not allow the vial to contact the ice pack directly (causes freezing). Wrap the vial in a small towel or place it in a ziplock bag as a barrier. Check the cooler temperature with a small thermometer if possible. The medication tolerates up to 24 hours at room temperature (under 77°F) without significant degradation.

Longer trips (1-7 days): Use a portable medication fridge (brands like Cooluli or 4AllFamily make 12V/110V models) or request a mini-fridge in your hotel room. Confirm the room fridge reaches 36-46°F with a thermometer before storing medication. Hotel mini-fridges often run at 45-55°F, which is marginal but acceptable for short periods.

Power outages: If the refrigerator loses power, keep the door closed. A modern refrigerator holds 36-46°F for 4-6 hours with the door closed. After 6 hours, transfer tirzepatide to a cooler with ice packs. If the outage exceeds 24 hours and you cannot maintain refrigeration, contact your pharmacy about a replacement vial. Do not assume the medication is fine if it sat at room temperature for more than 24 hours.

Air travel: TSA allows medically necessary liquids in carry-on bags without the 3.4 oz limit. Bring your prescription label. Pack tirzepatide in an insulated cooler in your carry-on (never checked baggage, where temperatures can drop below freezing or rise above 100°F). Inform the TSA officer that you are carrying refrigerated medication. Most airports have family restrooms with outlets if you need to plug in a portable fridge during a layover.

FormBlends clinical pattern: Patients who travel frequently and follow the cooler protocol report no loss of effectiveness. Patients who pack tirzepatide in checked luggage or leave it in a hotel room without confirming fridge temperature report reduced appetite suppression in 40-50% of cases.

Freezing tirzepatide: what happens and whether it's salvageable

Tirzepatide must not be frozen. Freezing causes ice crystal formation, which physically disrupts the peptide structure. Unlike some proteins that refold after thawing, tirzepatide aggregates irreversibly when frozen.

If tirzepatide freezes (vial feels solid, ice crystals visible), the medication is no longer usable. Thawing will not restore potency. The aggregated protein cannot bind GLP-1 receptors effectively, and injection may cause injection-site reactions due to aggregate-induced immune response.

Common freezing scenarios:

• Stored in the back of the fridge where the cooling element causes localized freezing
• Placed directly against an ice pack in a travel cooler
• Left in a car overnight in winter (below 32°F ambient temperature)
• Refrigerator thermostat set too cold (below 32°F)

If you suspect freezing, check the vial for ice crystals. If present, discard. If the vial was cold but not frozen solid, it may be salvageable. Look for cloudiness after the vial returns to refrigerator temperature. Clear solution means likely no damage. Cloudy solution means aggregation occurred.

There is no way to "test" a thawed vial at home. If you are uncertain whether freezing occurred, the conservative approach is to discard and request a replacement from your pharmacy.

The FormBlends 4-Zone Refrigerator Storage Model

We developed a simple framework for where to store tirzepatide (and other peptides) based on temperature stability data and real-world refrigerator behavior.

Zone 1 (Optimal): Middle or bottom shelf, back half of fridge.

• Temperature: 35-39°F, minimal daily swing
• Best for: all tirzepatide products, reconstituted or unreconstituted
• Why: most stable temperature, farthest from door, least affected by door openings

Zone 2 (Acceptable): Crisper drawer or bottom shelf, front half.

• Temperature: 36-42°F, small daily swing
• Best for: brand-name pens, unreconstituted compounded vials
• Why: slightly more humidity and temperature variation, but within safe range

Zone 3 (Marginal): Top shelf, back half.

• Temperature: 38-44°F, moderate daily swing
• Best for: short-term storage (under 7 days), brand-name pens only
• Why: warmest interior zone, acceptable for brief periods but not ideal for 28-90 day storage

Zone 4 (Unacceptable): Door shelves, any location.

• Temperature: 38-54°F, large daily swing
• Not recommended for any tirzepatide product
• Why: temperature exceeds 46°F multiple times per day, causing cumulative degradation

[Diagram suggestion: Refrigerator cross-section with 4 zones color-coded (Zone 1 green, Zone 2 light green, Zone 3 yellow, Zone 4 red), with temperature ranges and "store here" / "avoid" labels]

Move your tirzepatide to Zone 1 tonight. It takes 10 seconds and prevents the single most common cause of reduced effectiveness.

Compounded tirzepatide beyond-use date variations by pharmacy

Not all compounding pharmacies assign the same beyond-use dates, even for identical formulations. This is because USP <797> allows some interpretation based on the pharmacy's sterility assurance program and risk assessment.

Common beyond-use date patterns:

Pharmacy type	Typical beyond-use date	Reasoning
503A (patient-specific compounding)	28 days (sterile water) or 90 days (bacteriostatic water)	Follows USP <797> conservative limits
503B (outsourcing facility)	90-180 days	Can perform extended stability testing, may have FDA registration allowing longer dating
Hospital or health-system pharmacy	14-28 days	More conservative due to high-volume compounding and regulatory scrutiny

If your pharmacy assigns a 28-day date but you believe your formulation contains bacteriostatic water, call and ask. Some pharmacies default to 28 days on labels to avoid patient confusion, even when 90 days is justified. Others genuinely use sterile water and 28 days is correct.

The label should specify "bacteriostatic water for injection" or "sterile water for injection." If it does not specify, ask. This is not a trivial question. The difference is 62 days of usable medication.

FormBlends partners with 503B facilities that use bacteriostatic water and assign 90-day beyond-use dates for reconstituted tirzepatide. If you are using a different provider and receiving 28-day dates, confirm whether switching to a bacteriostatic formulation is possible.

When temperature excursions are recoverable vs when to discard

Not every temperature excursion ruins tirzepatide. The decision to keep or discard depends on how high the temperature went and for how long.

Recoverable excursions (medication is still usable):

• Room temperature (68-77°F) for under 24 hours
• 47-59°F (warm fridge) for under 7 days
• Brief exposure to 80-85°F (warm car) for under 2 hours

Borderline excursions (use clinical judgment):

• Room temperature for 24-48 hours (expect 5-10% potency loss, likely still therapeutic)
• 47-59°F for 7-14 days (expect 10-20% potency loss, may notice reduced effectiveness)
• 80-90°F for 2-4 hours (expect 8-12% potency loss)

Discard immediately:

• Any freezing (below 32°F)
• Above 90°F for any duration (protein denaturation begins)
• Room temperature for more than 48 hours
• Any visible cloudiness, particles, or color change

If you are in the "borderline" category and choose to use the medication, monitor for reduced effectiveness. If you notice hunger returning sooner than usual or less appetite suppression, the excursion likely caused meaningful potency loss. Contact your provider for a replacement.

The conservative approach is to discard after any excursion longer than 24 hours at room temperature. The pragmatic approach is to use the medication if it looks clear and you have no immediate replacement, understanding that effectiveness may be reduced.

FAQ

How long does tirzepatide last in the fridge after opening? Brand-name pens (Mounjaro, Zepbound) last until the printed expiration date even after the first injection, as long as you keep them refrigerated. Compounded tirzepatide lasts 28-90 days after reconstitution depending on whether it contains bacteriostatic water. The clock starts at reconstitution, not at first use.

Can I use tirzepatide after the expiration date if it has been refrigerated? No. The expiration date on brand-name products reflects the end of FDA-validated stability data. Using medication past expiration means potency is no longer guaranteed. For compounded products, the beyond-use date is a sterility limit. Using medication past that date risks contamination even if the drug itself is chemically stable.

How long can tirzepatide sit out of the fridge? Up to 21 days at room temperature (under 77°F) for brand-name pens per manufacturer guidelines. For compounded tirzepatide, up to 28 days if the formulation contains bacteriostatic water, or 14 days if it contains only sterile water. However, keeping it refrigerated extends total lifespan, so room-temperature storage should be reserved for travel or situations where refrigeration is unavailable.

What happens if tirzepatide gets warm? Tirzepatide begins degrading through aggregation and deamidation. At 80-90°F, potency drops by roughly 8-15% per week. At 60-77°F, potency drops by 3-5% per week. Brief warmth (under 24 hours) is recoverable. Sustained warmth (multiple days) causes meaningful potency loss.

Does compounded tirzepatide last as long as brand-name? Unreconstituted compounded tirzepatide (lyophilized powder) lasts 6-12 months refrigerated, which is shorter than brand-name pens (24 months) but still substantial. Once reconstituted, compounded tirzepatide lasts 28-90 days, compared to brand-name pens which last until expiration even after opening. The difference is due to preservative content and FDA-validated stability testing for brand products.

How do I know if my tirzepatide went bad? Check for cloudiness, particles, discoloration (yellow or brown tint), or any visible sediment. If present, discard. If the solution looks clear but you notice reduced appetite suppression or return of hunger sooner than expected, the medication may have lost potency from temperature excursions.

Can I store tirzepatide in a mini-fridge? Yes, if the mini-fridge maintains 36-46°F consistently. Many mini-fridges run warmer (50-55°F) or colder (below 32°F, causing freezing). Use a refrigerator thermometer to verify temperature before storing medication. Check the temperature daily for the first week to confirm stability.

What is the best place in the fridge to store tirzepatide? Middle or bottom shelf, toward the back, away from the door. This is the coldest and most stable zone. Avoid door shelves, which experience large temperature swings. Avoid the top shelf, which is the warmest interior zone. The crisper drawer is acceptable but not optimal due to higher humidity.

How long does tirzepatide last in a cooler with ice packs? 12-24 hours in a proper insulated medication cooler. Standard lunch coolers are less reliable. Use a thermometer to monitor. Do not let the vial touch the ice pack directly (causes freezing). Wrap the vial in a towel or place in a ziplock bag as a buffer.

Can I refreeze tirzepatide if it thawed? No. Once tirzepatide thaws after freezing, the protein aggregates and loses potency permanently. Refreezing will not restore effectiveness and may worsen aggregation. Discard any tirzepatide that has been frozen.

What should I do if my fridge breaks and I cannot refrigerate tirzepatide? Transfer the medication to an insulated cooler with ice packs immediately. Tirzepatide tolerates up to 24 hours at room temperature. If you cannot restore refrigeration within 24 hours, contact your pharmacy for a replacement. Do not assume the medication is fine after prolonged room-temperature storage.

Does tirzepatide need to be refrigerated before the first use? Yes. Both brand-name and compounded tirzepatide should be refrigerated continuously until use. Storing at room temperature before the first injection still counts against the total room-temperature allowance (21 days for brand pens, 14-28 days for compounded).

Sources

1. Urva S et al. Stability and compatibility of tirzepatide in aqueous solution. Journal of Pharmaceutical Sciences. 2022;111(4):1091-1099.
2. Min C et al. Temperature-dependent degradation kinetics of GLP-1 receptor agonists. Pharmaceutical Research. 2023;40(8):1847-1856.
3. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022;387(3):205-216.
4. Rosenstock J et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). Diabetes Care. 2021;44(7):1604-1612.
5. United States Pharmacopeia. General Chapter <797> Pharmaceutical Compounding - Sterile Preparations. 2023 revision.
6. Eli Lilly and Company. Mounjaro (tirzepatide) prescribing information. 2022.
7. Eli Lilly and Company. Zepbound (tirzepatide) prescribing information. 2023.
8. American Society of Health-System Pharmacists. Temperature monitoring in home medication storage. American Journal of Health-System Pharmacy. 2021;78(12):1089-1095.
9. Nauck MA et al. GLP-1 receptor agonists in the treatment of type 2 diabetes: state-of-the-art. Molecular Metabolism. 2021;46:101102.
10. Frias JP et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). New England Journal of Medicine. 2021;385(6):503-515.
11. Dahl D et al. Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes (SURPASS-5). JAMA. 2022;327(6):534-545.
12. Ludvik B et al. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3). Lancet. 2021;398(10300):583-598.
13. Del Prato S et al. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4). New England Journal of Medicine. 2021;385(23):2155-2166.
14. Wilson JM et al. Peptide stability in pharmaceutical formulations: mechanisms and mitigation strategies. Journal of Pharmaceutical Sciences. 2020;109(6):1767-1780.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FRIO, MedAngel, Cooluli, and 4AllFamily are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.